SICHUAN KELUN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.8 CNY | -1.85% |
|
-4.32% | +6.02% |
ETFs positioned on Sichuan Kelun Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.95% | 4 M€ | -2.96% | ||
| 0.66% | 1 M€ | -21.58% | - | |
| 0.45% | 2 M€ | -14.14% | ||
| 0.08% | 11 M€ | +6.31% | ||
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 451 M€ | +8.89% | - | |
| 0.00% | 2,838 M€ | +11.72% | - | |
| 0.00% | 152 M€ | +7.99% | - | |
| 0.00% | 114 M€ | +5.12% | - | |
| 0.00% | 35 M€ | +5.50% | - | |
| 0.00% | 36 M€ | +10.35% | - | |
| 0.00% | 414 M€ | +11.94% | - | |
| 0.00% | 40 M€ | +7.03% | - | |
| 0.00% | 324 M€ | +8.49% | - | |
| 0.00% | 32 M€ | +4.65% | - | |
| 0.00% | 104 M€ | +5.59% | - | |
| 0.00% | 7 M€ | +4.63% | - | |
| 0.00% | 55 M€ | +2.13% | - | |
| 0.00% | 15 M€ | +18.75% |
Sichuan Kelun Pharmaceutical Co., Ltd. specializes in developing, manufacturing and marketing pharmaceuticals. Net sales break down by activity as follows:
- manufacturing and sale of pharmaceutical products (98%). Net sales break down by family of products between injectable drugs (56.9%) and other (43.1%; tablets, capsules, granules, etc.);
- other (2%).
China accounts for 94.6% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
30.8
CNY
Average target price
42.04
CNY
Spread / Average Target
+36.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.02% | 6.75B | |
| +51.99% | 798B | |
| -5.72% | 356B | |
| +18.94% | 328B | |
| +11.07% | 304B | |
| +16.96% | 244B | |
| +2.25% | 227B | |
| +11.15% | 216B | |
| +7.59% | 166B | |
| -3.65% | 157B |
- Stock Market
- Equities
- 002422 Stock
- Funds and ETFs Sichuan Kelun Pharmaceutical Co., Ltd.
